Nektar Therapeutics
NKTR
#5792
Rank
$1.27 B
Marketcap
$37.28
Share price
0.07%
Change (1 day)
-35.68%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2023 (TTM): -$1.63

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is -$2.96. In 2022 the company made an earnings per share (EPS) of -$1.97 an increase over its 2021 EPS that were of -$2.86.

EPS history for Nektar Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.63-17.26%
2022-$1.97-31.12%
2021-$2.8614.86%
2020-$2.49-1.19%
2019-$2.52-163.96%
2018$3.94-725.4%
2017-$0.63-42.73%
2016-$1.1083.33%
2015-$0.6039.53%
2014-$0.43-69.29%
2013-$1.40-6.67%
2012-$1.5026.05%
2011-$1.19190.24%
2010-$0.41-63.06%
2009-$1.11200%
2008-$0.372.78%
2007-$0.36-79.19%
2006-$1.73-19.91%
2005-$2.1657.66%
2004-$1.3763.1%
2003-$0.84-56.7%
2002-$1.94-59.33%
2001-$4.77103.85%
2000-$2.3478.63%
1999-$1.31123.93%
1998-$0.5858.11%
1997-$0.37-15.91%
1996-$0.44

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
$6.68-325.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$0.76-125.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$16.22-647.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-$1.41-52.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$0.99-133.54%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$6.68-325.68%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
$0.45-115.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
$0.40-113.51%๐Ÿ‡ฎ๐Ÿ‡ช Ireland